Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

NCT00021229 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

85

Enrollment

NIH

Sponsor class

Stopped Poor accrual

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: imatinib mesylate
RADIATION: local irradiation therapy

Sponsor

National Cancer Institute (NCI)